These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 28424554)

  • 21. An expanded phase I/II trial of cyclophosphamide, etoposide, and carboplatin plus total body irradiation with autologous marrow or stem cell support for patients with hematologic malignancies.
    Shea TC; Bruner R; Wiley JM; Serody JS; Sailer S; Gabriel DA; Capel E; Moore DT; Dent G; Bentley S; Brecher ME
    Biol Blood Marrow Transplant; 2003 Jul; 9(7):443-52. PubMed ID: 12869958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phase I/II trial of cure-oriented high-dose chemoradiotherapy with transplantation of CD34+ peripheral blood stem cells purified by the immunomagnetic bead method for refractory hematological malignancies. Nagoya CD34+ PBSCT Study Group.
    Ogura M; Kagami Y; Suzuki R; Miura K; Uehira K; Kurokawa T; Ito T; Kinoshita T; Emi N; Morishima Y; Kodera Y; Ueda R
    Cancer Chemother Pharmacol; 1997; 40 Suppl():S51-7. PubMed ID: 9272135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Endothelial dysfunction and arterial wall stiffness: New targets in diabetic nephropathy].
    Murkamilov IT; Sabirov IS; Fomin VV; Yusupov FA
    Ter Arkh; 2017; 89(10):87-94. PubMed ID: 29171477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Day +100 Platelet Count Predicts Survival After Allogeneic Hematopoietic Stem-Cell Transplantation in Children With Hematologic Malignancies.
    Moneib H; Hafez H; Abdalla A; Hassanain O; Lehmann L; Haddad AE
    Clin Lymphoma Myeloma Leuk; 2019 May; 19(5):e221-e227. PubMed ID: 30846344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic factors in critically ill patients with hematologic malignancies admitted to the intensive care unit.
    Yeo CD; Kim JW; Kim SC; Kim YK; Kim KH; Kim HJ; Lee S; Rhee CK
    J Crit Care; 2012 Dec; 27(6):739.e1-6. PubMed ID: 23217573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Vascular age in patients with arterial hypertension].
    Bestavashvili AA; Bestavashvili AA; Saidova AI; Shchekochikhin DI; Kopylov FI; Syrkin AL
    Angiol Sosud Khir; 2020; 26(2):10-16. PubMed ID: 32597880
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COMPLETE BLOOD COUNT DERIVED INFLAMMATORY BIOMARKERS IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES.
    Nanava N; Betaneli M; Giorgobiani G; Chikovani T; Janikashvili N
    Georgian Med News; 2020 May; (302):39-44. PubMed ID: 32672687
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Autologous Stem-Cell Transplantation Without Hematopoietic Support for the Treatment of Hematologic Malignancies in Jehovah's Witnesses.
    Ford PA; Grant SJ; Mick R; Keck G
    J Clin Oncol; 2015 May; 33(15):1674-9. PubMed ID: 25870085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventricular-Arterial Coupling in Breast Cancer Patients After Treatment With Anthracycline-Containing Adjuvant Chemotherapy.
    Koelwyn GJ; Lewis NC; Ellard SL; Jones LW; Gelinas JC; Rolf JD; Melzer B; Thomas SM; Douglas PS; Khouri MG; Eves ND
    Oncologist; 2016 Feb; 21(2):141-9. PubMed ID: 26764251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolic syndrome in hematologic malignancies survivors: a meta-analysis.
    Li C; Liu P; Liu L; Zhang X; Yang P; Sheng H; Bu L; Li H; Qu S
    Med Oncol; 2015 Jan; 32(1):422. PubMed ID: 25471791
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased arterial stiffness in children treated with anthracyclines for malignant disease.
    Herceg-Cavrak V; Ahel V; Batinica M; Matec L; Kardos D
    Coll Antropol; 2011 Jun; 35(2):389-95. PubMed ID: 21755708
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adiponectin as a biomarker linking obesity and adiposopathy to hematologic malignancies.
    Dalamaga M; Christodoulatos GS
    Horm Mol Biol Clin Investig; 2015 Jul; 23(1):5-20. PubMed ID: 26057219
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of inflammation, arterial stiffness and traditional cardiovascular risk factors between rheumatoid arthritis and inflammatory bowel disease.
    Fan F; Galvin A; Fang L; White DA; Moore XL; Sparrow M; Cicuttini F; Dart AM
    J Inflamm (Lond); 2014; 11(1):29. PubMed ID: 25337037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mechanisms and clinical course of cardiovascular toxicity of cancer treatment II. Hematology
    Breccia M; Carver JR; Szmit S; Jurczak W; Salvatorelli E; Minotti G
    Semin Oncol; 2019 Dec; 46(6):403-407. PubMed ID: 31748121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modified busulfan and cyclophosphamide conditioning regimen for allogeneic hematopoietic stem cell transplantation in the treatment of patients with hematologic malignancies.
    Zhao XF; Mao XF; Wan DM; Liu W
    Transplant Proc; 2014 Jun; 46(5):1531-5. PubMed ID: 24935325
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoreduction of lymphoid malignancies and mobilization of blood hematopoietic progenitor cells with high doses of cyclophosphamide and etoposide plus filgrastim.
    Damon L; Rugo H; Tolaney S; Navarro W; Martin T; Ries C; Case D; Ault K; Linker C
    Biol Blood Marrow Transplant; 2006 Mar; 12(3):316-24. PubMed ID: 16503501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognosis of hematologic malignancies does not predict intensive care unit mortality.
    Massion PB; Dive AM; Doyen C; Bulpa P; Jamart J; Bosly A; Installé E
    Crit Care Med; 2002 Oct; 30(10):2260-70. PubMed ID: 12394954
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tandem transplantation with peripheral autologous hematopoietic blood stem cells in treatment of oncologic and hematologic malignancies. Initial results of the Donauspital, Vienna].
    Ruckser R; Kier P; Sebesta C; Kittl E; Kurz M; Selleny S; Höniger S; Scherz M; Habertheuer KH; Zelenka P
    Wien Med Wochenschr; 1995; 145(2-3):41-4, 46-7. PubMed ID: 7762251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of malignant hematologic diseases by peripheral blood stem cell transplantation combined with halotype lymphocyte infusion].
    Wu BY; Song CY; Guo KY; Yan DA; Yang YL; Xiao LL; Wu GX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Jun; 11(3):287-91. PubMed ID: 12844415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.